Thursday, April 13, 2017

British Journal of Cancer - Table of Contents alert Volume 116 Issue 8

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 116, Issue 8 (973-1118)
Published online 11 April 2017

In this issue
Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology
Letters to the Editor

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
 
Advertisement
BACR 2017 Conferences
The BACR hosts a number of specialist cancer meetings to bring together the latest thinking in cancer research. Having links with organisations such as EACR,NCRI and RSM boosts opportunities for networking and establishing collaborations with leaders in cancer research.
Interested in attending/or presenting then visit www.bacr.org.uk/events
 

Review

Top

A unified model of the hierarchical and stochastic theories of gastric cancer

Yanjing Song, Yao Wang, Chuan Tong, Hongqing Xi, Xudong Zhao, Yi Wang and Lin Chen

Br J Cancer 2017 116: 973-989; advance online publication, March 16, 2017; 10.1038/bjc.2017.54

Abstract | Full Text

Clinical Studies

Top

MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children

Veronica A Kinsler, Patricia O'Hare, Thomas Jacques, Darren Hargrave and Olga Slater

Br J Cancer 2017 116: 990-993; advance online publication, March 2, 2017; 10.1038/bjc.2017.49

Abstract | Full Text

Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index

A Carmona-Bayonas, P Jiménez-Fonseca, C Font, F Fenoy, R Otero, C Beato, J M Plasencia, M Biosca, M Sánchez, M Benegas, D Calvo-Temprano, D Varona, L Faez, I de la Haba, M Antonio, O Madridano, M P Solis, A Ramchandani, E Castañón, P J Marchena, M Martín, F Ayala de la Peña and V Vicente on behalf of the Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia (the Region of Murcia’s Association of Thromboembolic Disease Research)

Br J Cancer 2017 116: 994-1001; advance online publication, March 7, 2017; 10.1038/bjc.2017.48

Abstract | Full Text

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

Hui-Ming Lin, Kate L Mahon, Calan Spielman, Howard Gurney, Girish Mallesara, Martin R Stockler, Patricia Bastick, Karen Briscoe, Gavin Marx, Alexander Swarbrick and Lisa G Horvath

Br J Cancer 2017 116: 1002-1011; advance online publication, March 9, 2017; 10.1038/bjc.2017.50

Abstract | Full Text

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system

Jeong Mo Bae, Jung Ho Kim, Yoonjin Kwak, Dae-Won Lee, Yongjun Cha, Xianyu Wen, Tae Hun Lee, Nam-Yun Cho, Seung-Yong Jeong, Kyu Joo Park, Sae Won Han, Hye Seung Lee, Tae-You Kim and Gyeong Hoon Kang

Br J Cancer 2017 116: 1012-1020; advance online publication, March 9, 2017; 10.1038/bjc.2017.52

Abstract | Full Text

BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer

Michael J Pishvaian, Andrew V Biankin, Peter Bailey, David K Chang, Daniel Laheru, Christopher L Wolfgang and Jonathan R Brody

Br J Cancer 2017 116: 1021-1026; advance online publication, March 14, 2017; 10.1038/bjc.2017.40

Abstract | Full Text

Translational Therapeutics

Top

Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1

Li Xu, Yuanrun Zhu, Jinjin Shao, Min Chen, Hao Yan, Guanqun Li, Yi Zhu, Zhifei Xu, Bo Yang, Peihua Luo and Qiaojun He

Br J Cancer 2017 116: 1027-1036; advance online publication, March 7, 2017; 10.1038/bjc.2017.55

Abstract | Full Text

Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis

Stefan Holdenrieder, Birgit Wehnl, Karina Hettwer, Kirsten Simon, Steffen Uhlig and Farshid Dayyani

Br J Cancer 2017 116: 1037-1045; advance online publication, March 9, 2017; 10.1038/bjc.2017.45

Abstract | Full Text

Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer

K Yokoi, K Yamashita, S Ishii, T Tanaka, N Nishizawa, A Tsutsui, H Miura, H Katoh, T Yamanashi, M Naito, T Sato, T Nakamura and M Watanabe

Br J Cancer 2017 116: 1046-1056; advance online publication, March 14, 2017; 10.1038/bjc.2017.65

Abstract | Full Text

Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma

Yae-eun Suh, Katherine Lawler, Rhonda Henley-Smith, Lucy Pike, Russell Leek, Sally Barrington, Edward W Odell, Tony Ng, Francesco Pezzella, Teresa Guerrero-Urbano and Mahvash Tavassoli

Br J Cancer 2017 116: 1057-1064; advance online publication, March 21, 2017; 10.1038/bjc.2017.66

Abstract | Full Text

Molecular Diagnostics

Top

VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation

Premalatha Shathasivam, Alexandra Kollara, Thomasina Spybey, Soyeon Park, Blaise Clarke, Maurice J Ringuette and Theodore J Brown

Br J Cancer 2017 116: 1065-1076; advance online publication, March 16, 2017; 10.1038/bjc.2017.51

Abstract | Full Text

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

Takashi Sakaguchi, Hirofumi Yoshino, Masaya Yonemori, Kazutaka Miyamoto, Satoshi Sugita, Ryosuke Matsushita, Toshihiko Itesako, Shuichi Tatarano, Masayuki Nakagawa and Hideki Enokida

Br J Cancer 2017 116: 1077-1087; advance online publication, March 21, 2017; 10.1038/bjc.2017.43

Abstract | Full Text

Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries

Colin B Begg, Megan S Rice, Emily C Zabor and Shelley S Tworoger

Br J Cancer 2017 116: 1088-1091; advance online publication, March 23, 2017; 10.1038/bjc.2017.73

Abstract | Full Text

Epidemiology

Top

The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis

P G Vaughan-Shaw, F O'Sullivan, S M Farrington, E Theodoratou, H Campbell, M G Dunlop and L Zgaga

Br J Cancer 2017 116: 1092-1110; advance online publication, March 16, 2017; 10.1038/bjc.2017.44

Abstract | Full Text

The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT

Lesley Fallowfield, Ivonne Solis-Trapala, Usha Menon, Carolyn Langridge, Shirley May, Ian Jacobs and Valerie Jenkins for and on behalf of the UKCTOCS trialists

Br J Cancer 2017 116: 1111-1117; advance online publication, March 21, 2017; 10.1038/bjc.2017.72

Abstract | Full Text

Letters to the Editor

Top

Comment on ‘Statin use and all-cancer survival: prospective results from the Women’s Health Initiative’

Uffe Ravnskov

Br J Cancer 2017 116: e9; advance online publication, March 9, 2017; 10.1038/bjc.2017.41

Full Text

Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’

Kadri Altundag

Br J Cancer 2017 116: e10; advance online publication, March 14, 2017; 10.1038/bjc.2017.60

Full Text

Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’’

Takeo Fujii and Naoto T Ueno

Br J Cancer 2017 116: e11; advance online publication, March 14, 2017; 10.1038/bjc.2017.61

Full Text

Comment on ‘The burden of occupationally-related cutaneous malignant melanoma in Britain due to solar radiation’

William B Grant

Br J Cancer 2017 116: e12; advance online publication, March 16, 2017; 10.1038/bjc.2017.63

Full Text

Reply to ‘Comment on ‘The burden of occupationally-related cutaneous malignant melanoma in Britain due to solar radiation’’ – outdoor occupation may not be linked to increased risk of melanoma in Britain

Lesley Rushton and Sally J Hutchings

Br J Cancer 2017 116: e13; advance online publication, March 16, 2017; 10.1038/bjc.2017.64

Full Text

Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’

Keisuke Imafuku, Koji Yoshino, Kei Yamaguchi, Satoshi Tsuboi, Kuniaki Ohara and Hiroo Hata

Br J Cancer 2017 116: e14; advance online publication, March 21, 2017; 10.1038/bjc.2017.58

Full Text

Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’’

Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan, James Larkin, Grant McArthur, Victoria Atkinson, Michael Millward, Muoi Khou, Stefan Diem, Sangeetha Ramanujam, Ben Kong, Elizabeth Liniker, Alexander Guminski, Phillip Parente, Miles C Andrews, Sagun Parakh, Jonathan Cebon, Georgina V Long, Matteo S Carlino and Oliver Klein

Br J Cancer 2017 116: e15; advance online publication, March 21, 2017; 10.1038/bjc.2017.59

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

nature publishing group
 

No comments: